329 related articles for article (PubMed ID: 9623900)
1. Periodontal status and serum antibody responses to oral microorganisms in Sjögren's syndrome.
Celenligil H; Eratalay K; Kansu E; Ebersole JL
J Periodontol; 1998 May; 69(5):571-7. PubMed ID: 9623900
[TBL] [Abstract][Full Text] [Related]
2. Periodontal findings and systemic antibody responses to oral microorganisms in Behçet's disease.
Celenligil-Nazliel H; Kansu E; Ebersole JL
J Periodontol; 1999 Dec; 70(12):1449-56. PubMed ID: 10632520
[TBL] [Abstract][Full Text] [Related]
3. Periodontal conditions of individuals with Sjögren's syndrome.
Antoniazzi RP; Miranda LA; Zanatta FB; Islabão AG; Gustafsson A; Chiapinotto GA; Oppermann RV
J Periodontol; 2009 Mar; 80(3):429-35. PubMed ID: 19254127
[TBL] [Abstract][Full Text] [Related]
4. Periodontal status and sulcular Candida albicans colonization in patients with primary Sjögren's Syndrome.
Rhodus NL; Michalowicz BS
Quintessence Int; 2005 Mar; 36(3):228-33. PubMed ID: 15887508
[TBL] [Abstract][Full Text] [Related]
5. Clinical and microbiological studies of periodontal disease in Sjögren syndrome patients.
Kuru B; McCullough MJ; Yilmaz S; Porter SR
J Clin Periodontol; 2002 Feb; 29(2):92-102. PubMed ID: 11908470
[TBL] [Abstract][Full Text] [Related]
6. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down's syndrome.
Morinushi T; Lopatin DE; Van Poperin N
J Periodontol; 1997 Jul; 68(7):626-31. PubMed ID: 9249633
[TBL] [Abstract][Full Text] [Related]
7. Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus.
Takahashi K; Nishimura F; Kurihara M; Iwamoto Y; Takashiba S; Miyata T; Murayama Y
J Int Acad Periodontol; 2001 Oct; 3(4):104-11. PubMed ID: 12666949
[TBL] [Abstract][Full Text] [Related]
8. IgG antibody levels to Porphyromonas gingivalis and clinical measures in children.
Donley CL; Badovinac R; Sapir S; Shapira L; Houri Y; Kantarci A; Warbington ML; Dibart S; Van Dyke TE; Needleman HL; Karimbux N; Bimstein E
J Periodontol; 2004 Feb; 75(2):221-8. PubMed ID: 15068109
[TBL] [Abstract][Full Text] [Related]
9. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
[TBL] [Abstract][Full Text] [Related]
10. "Checkerboard" assessments of periodontal microbiota and serum antibody responses: a case-control study.
Papapanou PN; Neiderud AM; Papadimitriou A; Sandros J; Dahlén G
J Periodontol; 2000 Jun; 71(6):885-97. PubMed ID: 10914791
[TBL] [Abstract][Full Text] [Related]
11. Effect of initial therapy on dynamics of immunogloblin G levels to some periodontopathic bacteria in serum and gingival crevicular fluid.
Hosaka Y; Saito A; Nakagawa T; Seida K; Yamada S; Okuda K
Bull Tokyo Dent Coll; 1994 Nov; 35(4):207-16. PubMed ID: 8689734
[TBL] [Abstract][Full Text] [Related]
12. The relationship between gingivitis and colonization by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in children.
Morinushi T; Lopatin DE; Van Poperin N; Ueda Y
J Periodontol; 2000 Mar; 71(3):403-9. PubMed ID: 10776927
[TBL] [Abstract][Full Text] [Related]
13. Periodontal status of patients with Sjögren's syndrome: a cross-sectional study.
Tseng CC
J Formos Med Assoc; 1991 Jan; 90(1):109-11. PubMed ID: 1679104
[TBL] [Abstract][Full Text] [Related]
14. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
Rams TE; Listgarten MA; Slots J
J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
[TBL] [Abstract][Full Text] [Related]
15. Metabolic diseases and their possible link to risk indicators of periodontitis.
Noack B; Jachmann I; Roscher S; Sieber L; Kopprasch S; Lück C; Hanefeld M; Hoffmann T
J Periodontol; 2000 Jun; 71(6):898-903. PubMed ID: 10914792
[TBL] [Abstract][Full Text] [Related]
16. Microbiologic and immunologic characteristics of periodontal disease in Hispanic americans with type 2 diabetes.
Ebersole JL; Holt SC; Hansard R; Novak MJ
J Periodontol; 2008 Apr; 79(4):637-46. PubMed ID: 18380556
[TBL] [Abstract][Full Text] [Related]
17. Oral and periodontal status in Sjögren's syndrome.
al-Hashimi I
Tex Dent J; 2001 Oct; 118(10):932-9. PubMed ID: 11764624
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects.
Colhoun HM; Slaney JM; Rubens MB; Fuller JH; Sheiham A; Curtis MA
J Periodontal Res; 2008 Feb; 43(1):103-10. PubMed ID: 18230111
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of periodontal disease in patients with Sjögren's syndrome.
Najera MP; al-Hashimi I; Plemons JM; Rivera-Hidalgo F; Rees TD; Haghighat N; Wright JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):453-7. PubMed ID: 9127376
[TBL] [Abstract][Full Text] [Related]
20. Analysis of in situ proliferative activity in oral gingival epithelium in patients with xerostomia.
Celenligil-Nazliel H; Palali A; Ayhan A; Ruacan S
J Periodontol; 2003 Feb; 74(2):247-54. PubMed ID: 12666714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
